Invasive Haemophilus influenzae type b (Hib) disease is an important health problem. It is the most common cause of bacterial meningitis in the United States and is an important agent causing septic arthritis, pneumonia, and bacteremia in children (7) . Infants rarely produce antibodies to polyribosyl-ribose-phosphate (PRP) after an invasive Hib infection, and vaccines consisting solely of the carbohydrate capsule of Hib are not reliably immunogenic in children less than 18 months of age, the target population at the greatest risk. An alternative vaccine approach is to make the type b carbohydrate capsule, PRP, T dependent by coupling it to a protein. Current conjugate vaccines consist of PRP-tetanus toxoid (37) , PRP oligosaccharide coupled to CRM (a mutant diphtheria toxin) (1), PRP-diphtheria toxoid mixture (22) , or a meningococcal outer membrane protein (OMP) coupled to PRP (25) . Resultant carbohydrate-protein conjugates have been administered to infants as young as 2 months and have been shown to be immunogenic (1, 22, 25, 37) . Since antibodies directed against Hib OMP are protective in animal models of Hib invasive disease (24) , a conjugate vaccine composed of a Haemophilus OMP and the capsular carbohydrate might afford additional protection.
No single OMP on wild-type strains is consistently antigenic after bacteremia and meningitis; however, antibodies to a variety of OMPs are found after bacteremic Hib infections (13, 17) . This has led to the search for a highly conserved, antibody-accessible OMP or OMP epitope as a candidate for conjugating to PRP. Candidate OMPs from Hib (8) have included the major outer membrane porin, a 39-kDa protein, subsequently called P2 (3) or "b" (27) ; a 46-kDa OMP identified as P1 (3) or "a" (27) ; and a 16-kDa protein associated with lipid, identified as P6 (3) or "g" (27) , the last * Corresponding author. presumably analogous to the Braun transmembrane lipoprotein of Escherichia coli (11) .
The ideal OMP from Hib to be used as a vaccinogen should be highly conserved. In studies of the immunogenicity of whole bacteria in rabbits, our associates found that a 28-kDa membrane protein is present in a variety of haemophili, including nontypeable H. influenzae as well as Haemophilus parainfluenzae, and appears to be antigenically conserved (12) . Antibodies directed against a 28-kDa protein present in LiCl-EDTA extracts have been identified in the sera of patients convalescing from Hib meningitis in several studies (13, 17) . We found that rabbit polyclonal antibody raised to the purified pili of Hib cross-reacted with a 28-kDa protein in the same strain. Since other pilus-associated proteins have a role in adherence (28), we sought to examine the role of this protein in virulence for infant rats and monkeys.
MATERIALS AND METHODS
Bacterial strains and plasmids. The H. influenzae strains used in these experiments are described in Table 1 . Growth media used for H. influenzae consisted of brain heart infusion (BHI) broth supplemented with hemin hydrochloride (10 ,ug/ml) and P-NAD (10 ,ug/ml) (BHI) (39) . Solid medium was prepared from the same broth but containing 1.5 g of agar per 100 ml; streptomycin at 500 ,g/ml was added when strain Ela and its derivatives were studied. E. coli HB101 and DH5oL were used for cloning experiments. E. coli strains were grown on L agar containing the appropriate antibiotics. A HaeII fragment from plasmid pACYC 184 (6) was used as the source of the chloramphenicol acetyltransferase (CAT) gene. The cosmid vector pHC79 (19) and plasmid vector pUC 18/19 derivatives (43) were used for subcloning experiments. (21) . DNA was then partially digested with Sau3A and fractionated on a sodium chloride gradient as described elsewhere (38) . Fragments ranging in size from 20 to 40 kb were then ligated to BamHI-cleaved pHC79 (19) . DNA plasmid was designated pMCC1. The location of the 28-kDa gene was determined by mapping ATnS insertions (X b221 rex: :TnS c1857, Oam8, Pam29 [9] ). When the location of the gene encoding the 28-kDa protein was determined, a 5.2-kb CvnI-SstI fragment was subcloned into pUC18; the recombinant plasmid was designated pARS1. Deletions in pARS1 were created with E. coli exonuclease III and cloned into bacteriophage M13 derivatives for sequence analysis (43) .
DNA sequence analysis. DNA sequence analysis was completed for both strands by the method of Sanger (34) . The Klenow fragment of E. coli polymerase (Boehringer Mannheim, Indianapolis, Ind.) or avian myeloblastosis virus reverse transcriptase was used for sequencing with [35S]5' a-thio-dATP purchased from New England Nuclear Corp. (Boston, Mass.) (29) . The universal primer for M13 was purchased from New England BioLabs, while other primers were based on derived sequences; 12-to 20-mers were synthesized on a DNA synthesizer (Biosearch BioSystems). Sequence data was analyzed on a VAX/VMS computer using the University of Wisconsin Genetics Computer Group program (10).
DNA probe preparation and hybridizations. Appropriate restriction fragments were radiolabeled with a-32P-dATP by random hexamer priming (14) . For colony hybridization, H. influenzae strains were plated on sBHI and grown overnight at 37°C in 5% CO2 and the colonies were transferred to nitrocellulose. The membrane was air dried, immersed in a Tris-saline, dried, and prehybridized with salmon sperm DNA in 50% formamide (15) . The radiolabeled probe was added, and the membrane was washed at high stringency and autoradiographed.
For Southern blots, DNA was prepared from total H. influenzae strains by the method of Hull et al. (21) . DNA was subjected to EcoRI digestion and agarose gel electrophoresis on a 0.7% gel. The DNA was transferred overnight to nylon-backed nitrocellulose as suggested by the manufacturer. The membranes were then hybridized to probes labeled with digoxigenin-dUTP (Boehringer Mannheim) by random hexamer priming for 6 h at 68°C (38) . DNA fragments which hybridized to the probes were detected by reacting the blots with sheep antidigoxigenin Fab fragments conjugated to alkaline phosphatase (Boehringer Mannheim), by using 5-bromo-4-chloro-3-indolyl phosphate and Nitro Blue Tetrazolium.
Construction of 28-kDa mutants. pARSl (see below) was digested with EcoRI, and the ends were filled by a Klenow fragment-mediated reaction. The 1.4-kb HaeII fragment from pACYC 184 which contains the CAT gene was ligated into this site, and the resulting plasmid was transformed into HB101. CAT-producing strains were selected by a rapid screening method (2); several had detectable CAT activities and encoded chloramphenicol resistance (MIC, >20 ,ug/ml). The recombinant plasmid was purified by cesium chloride ethidium gradient centrifugation, digested to completion with PstI, and transformed into Hib strains. Transformation was accomplished by the competence procedure of Herriot et al. (18) . Transformants were selected on sBHI agar containing chloramphenicol at 2 ,ug/ml. Transformation of R1369 yielded strain 5-9; transformation of Ela yielded strain 5-4.
Analytical methods. Protein concentrations were measured by a modification of the method of Lowry (32) . SDS-PAGE was performed on 10% modified Laemmli gels (23) as performed previously (41 tures. These monolayers were used for assessment of the mean residence time by a kinetic method (39) .
Adherence in vivo was tested by the following manner: 108 CFU Iof each bacterial strain was separately inoculated intranasally into individual infant M. nemestrina of either sex between the ages of 1 and 3 days (36) . Twenty-four hours after intranasal inoculation and daily for 7 days, a Calgi swab was inserted into the right nostril, removed, and agitated in 1 ml of sterile PBS containing 0.1% gelatin (PBS-G); 0.1 ml of this and serial 10-fold dilutions were plated on sBHI agar containing streptomycin (500 ,ug/ml) and incubated overnight, and H. influenzae colonies were enumerated.
Similar experiments were performed with 5-day-old COBS/CD outbred Sprague-Dawley rats by the technique previously described (31) . However, with rats, 10 ,ul containing 105 CFU was inoculated into each nostril. At 1 day after inoculation and daily for 5 days, a Calgi swab was inserted into the right nostril and streaked on sBHI agar containing streptomycin at 500 ,ug/ml. In a separate series of experiments, the invasion potential in 5-day-old infant rats was assessed by obtaining blood from the external jugular vein 48 h after intranasal (31) or intraperitoneal (40) inoculation. Quantitative blood cultures were performed by plating undiluted blood as well as 1:10 and 1:100 dilutions in PBS-G on sBHI agar containing streptomycin. In selected animals, cerebrospinal fluid was obtained for culture (31) .
Nucleotide sequence accession number. The GenBank accession number for the DNA sequence is M59804.
RESULTS
Antigenicity. After recognizing that rabbit antisera raised by immunization with the R1369 pili reacted on dot blots with a variety of capsulated and untypeable H. influenzae strains, we examined the specificity of the reaction by Western blot. Antiserum raised against purified pili failed to detect the 22-kDa pilin subunit after separation on denaturing gels, although a protein of approximately 28 kDa was detected in the purified pilus preparation and Hib lysates which were examined (Fig. 1) . Because of the apparent cross-reactivity, we sought to determine whether this pro- tein was related to colonization and invasion. The reactivity at the top of the blot is apparently a trimer of the subunit, as prolonged boiling prior to SDS-PAGE yielded a single band with Coomassie blue and antisera. This protein was of a greater apparent mass than the fimbrial subunit.
Cloning. A cosmid library of DNA from Hib strain R1369 was screened by colony immunoblot with rabbit antiserum raised against R1369 pili; 8 of 1,000 clones screened were reactive with the antisera. Proteins from these eight clones were subjected to Western blot analysis. One colony was found to produce a 28-kDa protein which bound immunoglobulin in postimmunization antisera (data not shown). Plasmid DNA was purified from this strain, which harbored a recombinant plasmid, designated pKKW1, and contained a 40-kb insert chromosomal DNA from strain R1369. This plasmid was digested with AvaI, religated to itself, and transformed into HB101.
Two transformants were reactive by colony blot. One, designated pMCC1, expressed a protein of approximately 28 kDa in mass by Western blot analysis. This protein bound with mouse and rabbit polyclonal antibodies raised against purified pili. Mouse polyclonal antibody was used to confirm the results obtained with rabbit antisera (data not shown). A restriction map of pMCC1 was derived, and the location of the gene for the 28-kDa protein was determined by mapping XTnS insertions (Fig. 2) , which inactivated production of the immunologically reactive 28-kDa protein by using mouse ascitic fluid. An SstI-CvnI fragment from pMCC1 was blunt ended with the Klenow fragment, cloned into the SmaI site of alkaline phosphatase-treated pUC18, and identified as pARS1 (Fig. 3) . This plasmid was found to encode for production of the immunoreactive 28-kDa protein by Western blot analysis with mouse polyclonal antibody. Both strands of this DNA fragment were sequenced and, an 843-bp open reading frame extending from nucleotide 88 to the TAA stop codon at nucleotide 907 was found (Fig. 4) . Seven nucleotides 5' to the initiator methionine is AAGG, a putative ribosome-binding site. Comparison of the predicted translation product of the open reading frame with other proteins logged in the GenBank data base revealed significant homology with the E. coli 28-kDa lipoprotein (44) . Thirty-two bases upstream of the start codon is the sequence TTAAAC. This is similar to the E. coli consensus promoter TTGACA and identical to the putative promoter for the E. coli 28-kDa lipoprotein NlpA gene (44) . We prepared from pARSI a PstI-NdeI fragment internal to the coding region for the 28-kDa protein and used it as a probe for homologous sequences. This fragment was labeled with digoxigenin- dUTP and used to probe the EcoRI-restricted DNA of strains R1369, R1010, C54, and Ela (Fig. 5) . These strains all contain a 3.2-kb fragment which hybridized to the intragenic probe.
Conservation of the 28-kDa protein. An intragenic probe (Fig. 3) for the 28-kDa protein was also used in dot blot assays to determine whether this gene is highly conserved in H. influenzae. phenicol resistance but failed to encode the production of the 28-kDa immunoreactive protein, according to Western blot analysis with mouse ascitic fluid. The insertionally inactivated gene was introduced into H. influenzae by transformation of strain Ela with PstI-digested pSLM1. A chloramphenicol-resistant transformant of Ela selected for further study was designated strain 5-4. Strain 5-4 failed to produce the 28-kDa immunoreactive protein on Western blot analysis (Fig. 5) . We also observed on certain Western blots rabbit sera bound to an H. influenzae protein present in whole cells with a relative mobility of 38 to 41 kDa. This band was not seen if cell lysate supernatants were analyzed by Western blot with the same sera. Transformation of strain R1369 with PstI-digested pSLM1 yielded similar transformants. One, designated 5-9, lacked the 28-kDa protein (Fig. 5 ) but remained fimbriated on electron microscopic examination (data not shown). Southern blot analysis using the 28-kDa protein gene probe described above demonstrated an increase in the size of the 3.2-kb EcoRI fragment containing the 28-kDa-protein-encoding gene to 4.1 kb in strains 5-4 and 5-9 (Fig. 6 ). To confirm that the increase in the size of the fragment in strains 5-4 and 5-9 was due to the presence of the CAT gene, a 1.3-kb probe was prepared from pACYC 184. This probe consisted of a HaeII fragment from pACYC 184 and contained one EcoRI site and all of the CAT structural gene. When EcoRI digests of these strains were probed with the CAT gene, homologous sequences were seen only in strains 5-4 and 5-9 and were present on 4.1 kb fragments. The larger fragments of strains 5-4 and 5-9 seen hybridizing with the probes in Fig. 6 and 7 were due to the presence of the EcoRI site in the CAT gene. The non-CAT-producing strains did not hybridize with the CAT probe.
Virulence. We found no difference in the adherence of strains lacking or possessing the 28-kDa protein as observed by an in vitro kinetic method (39 significantly compromised in its ability to produce bacteremia and meningitis in comparison with its parent strain Ela. Strain R1369, the hyperpiliated derivative of Ela, was drastically reduced in virulence. The few animals that did become bacteremic with R1369 and 5-9 yielded from their blood organisms that were nonpiliated (data not shown). This indicates that the hyperpiliation phenotype interfered with the ability of the organisms to invade respiratory epithelium. Strain 5-9, the mutant of R1369 unable to express the 28-kDa protein, was indistinguishable from its parent strain in this model. When the four strains were inoculated intraperitoneally, all were able to produce bacteremia, suggesting that the primary contribution to virulence of the 28-kDa protein involves the initial process of invasion. However, when the densities of bacteremia produced by the different strains were compared following intraperitoneal challenge, the 28-kDa-protein-producing mutants 5-4 and 5-9 were recovered in significantly lower numbers than their parent strains Ela and R1369 ( (44) (Fig. 8) , a cytoplasmic membrane protein of E. coli. The Hib 28-kDa immunoreactive protein may be identical to Hib P5 as described by Barenkamp and coworkers (3) , "e" as described by Loeb and Smith (26) , and D* as described by van 
